申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US03974168A1
公开(公告)日:1976-08-10
Compounds of the formula: ##SPC1## Wherein Of X.sup.1 and X.sup.2 is a hydrogen atom, a halogen atom or an alkyl group having 1 to 4 carbon atoms; R.sup.1 is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkenyl group having 2 to 4 carbon atoms, an alkynyl group having 2 to 4 carbon atoms or a group -B.sup.1 -R.sup.3 (wherein B.sup.1 is an alkylene group having 1 to 4 carbon atoms, and R.sup.3 is a carboxyl group, an alkoxycarbonyl group in which the alkoxy moiety has 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms or a di-alkyl-amino group in which each alkyl moiety has 1 to 4 carbon atoms); R.sup.2 is an alkyl group having 1 to 4 carbon atoms or a group -B.sup.2 -R.sup.4 (wherein B.sup.2 is an alkylene group having 2 to 4 carbon atoms, and R.sup.4 is a carboxyl group or a di-alkyl-amino group in which each alkyl moiety has 1 to 4 carbon atoms); A is a methylene group or a carbonyl group; Y is an oxygen atom, a sulfur atom or an alkyl-imino group in which the alkyl moiety has 1 to 4 carbon atoms; and Ring P is a pyridine ring; and Pharmaceutically acceptable salts thereof are disclosed. They are useful as anti-inflammatory agents, analgesics, antipyretics and antirheumatics.
该化合物的公式为:## SPC1 ## 其中X1和X2是氢原子,卤素原子或具有1至4个碳原子的烷基; R1是氢原子,具有1至4个碳原子的烷基,具有2至4个碳原子的烯基,具有2至4个碳原子的炔基或-B1-R3(其中B1是具有1至4个碳原子的烷基,而R3是羧基,具有1至4个碳原子的烷氧羰基,具有1至4个碳原子的烷氧基或每个烷基都具有1至4个碳原子的双烷基氨基基); R2是具有1至4个碳原子的烷基或-B2-R4(其中B2是具有2至4个碳原子的烷基,而R4是羧基或每个烷基都具有1至4个碳原子的双烷基氨基基); A是亚甲基或羰基; Y是氧原子,硫原子或碳原子数量为1至4的烷基亚胺基; Ring P是吡啶环;以及其药学上可接受的盐。它们可用作抗炎药,镇痛剂,退烧剂和抗风湿药。